Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
AstraZeneca
McKinsey
Express Scripts
Dow

Last Updated: March 30, 2023

Patent: 7,183,057


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $100
Remove trial restrictions


Summary for Patent: 7,183,057
Title:Tape stripping methods for analysis of skin disease and pathological skin state
Abstract: The present invention provides non-invasive methods for detecting, monitoring, and diagnosing skin disease and pathological skin states such as irritated skin and psoriasis. The methods include using tape stripping to analyze expression in epidermal samples, of one or more skin markers. In illustrative examples, the tape stripping is performed using pliable tape that has a rubber adhesive. Furthermore, the present invention provides methods for predicting and monitoring response to therapy for a skin disease, such as psoriasis or dermatitis. Finally, the methods can include the use of a microarray.
Inventor(s): Benson; Nicholas R. (San Diego, CA)
Assignee: Dermtech International (San Diego, CA)
Application Number:10/816,457
Patent Claims:see list of patent claims

Details for Patent 7,183,057

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Immunex Corporation ENBREL etanercept For Injection 103795 11/02/1998 ⤷  Sign Up 2039-02-26
Immunex Corporation ENBREL etanercept For Injection 103795 05/27/1999 ⤷  Sign Up 2039-02-26
Immunex Corporation ENBREL etanercept Injection 103795 09/27/2004 ⤷  Sign Up 2039-02-26
Immunex Corporation ENBREL etanercept Injection 103795 02/01/2007 ⤷  Sign Up 2039-02-26
Immunex Corporation ENBREL MINI etanercept Injection 103795 09/14/2017 ⤷  Sign Up 2039-02-26
Immunex Corporation ENBREL etanercept Injection 103795 ⤷  Sign Up 2039-02-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Dow
McKinsey
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.